10-Q Filing

ARROWHEAD PHARMACEUTICALS, INC. CIK: 879407 Q1 2020

Filing Information

Form Type	10-Q
Accession Number	`0001564590-20-003465`
Period End Date	20191231
Filing Date	20200205
Fiscal Year	2020
Fiscal Period	Q1
XBRL Instance	arwr-10q_20191231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 30 Cash Flow Statement 48 Stockholders Equity 19

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	95.51M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	101.11M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$221.80M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$461.03M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	101.11M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$661.36K	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$1.35M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	95.51M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$2.73M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$3.32M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.53M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$2.56M	USD	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$36.90M	USD	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$40.97M	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$265.25M	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$507.61M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$23.21M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$26.43M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$17.06M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$16.64M	USD	Point-in-time
Long term investments	`HeldToMaturitySecuritiesNoncurrent`	$26.33M	USD	Point-in-time
Long term investments	`HeldToMaturitySecuritiesNoncurrent`	$44.18M	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$10.44M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$144.15K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$144.15K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$349.85M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$587.60M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$12.20M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$7.65M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$6.50M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$3.99M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$2.99M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$4.96M	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	$461.18K	USD	Point-in-time
Deferred rent	`DeferredRentCreditCurrent`	$173.95K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$77.77M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$54.03M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$16.56K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$16.56K	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$97.07M	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$73.70M	USD	Point-in-time
Lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$14.38M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$3.70M	USD	Point-in-time
Deferred revenue, net of current portion	`ContractWithCustomerLiabilityNoncurrent`	$5.04M	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$8.74M	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$14.38M	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 101,111,797 and 95,506,271 shares issued and outstanding as of December 31, 2019 and September 30, 2019, respectively	`CommonStockValue`	$187.88K	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 101,111,797 and 95,506,271 shares issued and outstanding as of December 31, 2019 and September 30, 2019, respectively	`CommonStockValue`	$193.48K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$922.05M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$664.09M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-195.55K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-391.62K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-421.96M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-419.29M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders' equity	`StockholdersEquity`	$500.08M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders' equity	`StockholdersEquity`	$244.59M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$499.53M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$171.50M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.24M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$244.04M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$587.60M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$349.85M	USD	Point-in-time

Income Statement 30 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`RevenueFromContractWithCustomerExcludingAssessedTax`	$29.45M	USD	1 Quarter
REVENUE	`RevenueFromContractWithCustomerExcludingAssessedTax`	$34.66M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$23.37M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$17.57M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$10.93M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$6.14M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$23.71M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$34.31M	USD	1 Quarter
OPERATING INCOME (LOSS)	`OperatingIncomeLoss`	$-4.85M	USD	1 Quarter
OPERATING INCOME (LOSS)	`OperatingIncomeLoss`	$10.95M	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$1.09M	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$2.18M	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$1.09M	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$2.18M	USD	1 Quarter
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$12.04M	USD	1 Quarter
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.67M	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$12.04M	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$-2.67M	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - BASIC	`EarningsPerShareBasic`	$-0.03	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - BASIC	`EarningsPerShareBasic`	$0.13	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - DILUTED	`EarningsPerShareDiluted`	$0.13	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - DILUTED	`EarningsPerShareDiluted`	$-0.03	USD	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	91.09M	shares	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	97.09M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	95.59M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	97.09M	shares	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-22.18K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$196.07K	USD	1 Quarter
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$12.02M	USD	1 Quarter
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$-2.48M	USD	1 Quarter

Cash Flow Statement 48 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-2.67M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$12.04M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$2.72M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$4.49M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$1.26M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$1.18M	USD	1 Quarter
Amortization/(accretion) of note premiums	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-177.45K	USD	1 Quarter
Amortization/(accretion) of note premiums	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$156.64K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$2.84M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$683.94K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.38M	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$120.91K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$158.10M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-28.77M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$4.55M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.13M	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-3.49M	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-4.21M	USD	1 Quarter
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$953.19K	USD	1 Quarter
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$-265.84K	USD	1 Quarter
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$168.28M	USD	1 Quarter
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-23.53M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.32M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$737.49K	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$69.27M	USD	1 Quarter
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$2.25M	USD	1 Quarter
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$13.60M	USD	1 Quarter
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$9.28M	USD	1 Quarter
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$-67.76M	USD	1 Quarter
Principal payments on notes payable	`RepaymentsOfNotesPayable`	$2.42M	USD	1 Quarter
Proceeds from the exercises of stock options	`ProceedsFromStockOptionsExercised`	$1.00M	USD	1 Quarter
Proceeds from the exercises of stock options	`ProceedsFromStockOptionsExercised`	$3.00M	USD	1 Quarter
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$60.52M	USD	1 Quarter
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$250.50M	USD	Point-in-time
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$250.48M	USD	1 Quarter
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$253.48M	USD	1 Quarter
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$59.11M	USD	1 Quarter
NET INCREASE (DECREASE) IN CASH	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$159.64M	USD	1 Quarter
NET INCREASE (DECREASE) IN CASH	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$239.23M	USD	1 Quarter
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$461.03M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$221.80M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$30.13M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$189.77M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$461.03M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$221.80M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$30.13M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$189.77M	USD	Point-in-time
Interest paid	`InterestPaidNet`	$27.44K	USD	1 Quarter

Stockholders Equity 19 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$499.53M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$171.50M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.24M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$244.04M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$4.49M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.72M	USD	1 Quarter
Exercise of stock options, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.00M	USD	1 Quarter
Exercise of stock options, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.00M	USD	1 Quarter
Exercise of stock options, Shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	472,193.00	shares	1 Quarter
Common stock - issued for cash, Amount	`StockIssuedDuringPeriodValueNewIssues`	$60.52M	USD	1 Quarter
Common stock - issued for cash, Amount	`StockIssuedDuringPeriodValueNewIssues`	$250.48M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-22.18K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$196.07K	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-2.67M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$12.04M	USD	1 Quarter
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$499.53M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$171.50M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.24M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$244.04M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.